These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11775905)
1. [Microsatellite instability in endometrial neoplasms correlation with clinicopathologic parameters and estrogen receptor or progesterone receptor status]. Song Y; Lang J Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):273-6. PubMed ID: 11775905 [TBL] [Abstract][Full Text] [Related]
2. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study. Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247 [TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability in endometrial cancer: relation to histological subtypes. Tibiletti MG; Furlan D; Taborelli M; Facco C; Riva C; Franchi M; Cossu A; Trubia M; Taramelli R; Capella C Gynecol Oncol; 1999 May; 73(2):247-52. PubMed ID: 10329042 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. Caduff RF; Johnston CM; Svoboda-Newman SM; Poy EL; Merajver SD; Frank TS Am J Pathol; 1996 May; 148(5):1671-8. PubMed ID: 8623934 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591 [TBL] [Abstract][Full Text] [Related]
6. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity. Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818 [TBL] [Abstract][Full Text] [Related]
7. [Estrogen and progesterone receptors in endometrial carcinoma]. Guo Y; Dang Q Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729 [TBL] [Abstract][Full Text] [Related]
8. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring. Kohlberger PD; Kieback DG; Breitenecker F; Loesch A; Gitsch G; Kainz C; Breitenecker G Gynecol Oncol; 1997 Mar; 64(3):404-10. PubMed ID: 9062141 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma. Suthipintawong C; Wejaranayang C; Vipupinyo C J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508 [TBL] [Abstract][Full Text] [Related]
10. [Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma]. Chen YP; Shen M; Chen C Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):123-5. PubMed ID: 12536641 [TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer. Caldés T; Perez-Segura P; Tosar A; de La Hoya M; Diaz-Rubio E Teratog Carcinog Mutagen; 2000; 20(5):283-91. PubMed ID: 10992275 [TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium. Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817 [TBL] [Abstract][Full Text] [Related]
13. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Lax SF; Kurman RJ Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874 [TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and somatic mutations in endometrial carcinomas. Sakamoto T; Murase T; Urushibata H; Kato K; Takada H; Imamura T; Mori H; Wake N Gynecol Oncol; 1998 Oct; 71(1):53-8. PubMed ID: 9784319 [TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129 [TBL] [Abstract][Full Text] [Related]
16. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas. Olech-Fudali E; Chibowski D; Skomra D; Walczyna B Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333 [TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046 [TBL] [Abstract][Full Text] [Related]
18. [Correlation between receptor status and results of treatment in endometrial carcinoma]. Baĭnazarova AA; Iskakova ZhK Vopr Onkol; 2006; 52(6):654-8. PubMed ID: 17338243 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability is correlated with lymph node-positive breast cancer. De Marchis L; Contegiacomo A; D'Amico C; Palmirotta R; Pizzi C; Ottini L; Mastranzo P; Figliolini M; Petrella G; Amanti C; Battista P; Bianco AR; Frati L; Cama A; Mariani-Costantini R Clin Cancer Res; 1997 Feb; 3(2):241-8. PubMed ID: 9815679 [TBL] [Abstract][Full Text] [Related]
20. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival. Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]